Birdwatch Note Rating
2024-11-29 02:29:23 UTC - HELPFUL
Rated by Participant: 3C786B9EB94D54204655677473AD8E5409A3527E66BCDF20BF01F93E1667DE25
Participant Details
Original Note:
The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a
All Note Details